Sandbox reserved 1169
From Proteopedia
Line 3: | Line 3: | ||
== Introduction == | == Introduction == | ||
The neurotensin receptor (NTSR1) belongs to the superfamily of proteins known as [http://proteopedia.org/wiki/index.php/G_protein-coupled_receptor G protein-coupled receptors] (GPCRs) and responds to the 13 amino acid hormone neurotensin (NT). There are currently around 800 G protein-coupled receptors that have been identified and are thought to be responsible for roughly 80% of signal transduction across the cell membrane.(reference year in g protein) These receptors are involved in a vast array of physiological processes within the body that range from interactions with dopamine to effects on secretion of bile in the intestines.(reference enhancement jujunem) (Reference dopamine) Due to the vast array of functions that these proteins serve and their high abundance within the body, these proteins have become a major site of drug targets in medicine making a deeper, more in depth understanding of these proteins very important. (drug discovery) There are currently no NTRS1 structures of the inactive state, so there is no way to determine the conformational changes of the binding pocket caused by the binding of NT. (reference Agonist-bound) | The neurotensin receptor (NTSR1) belongs to the superfamily of proteins known as [http://proteopedia.org/wiki/index.php/G_protein-coupled_receptor G protein-coupled receptors] (GPCRs) and responds to the 13 amino acid hormone neurotensin (NT). There are currently around 800 G protein-coupled receptors that have been identified and are thought to be responsible for roughly 80% of signal transduction across the cell membrane.(reference year in g protein) These receptors are involved in a vast array of physiological processes within the body that range from interactions with dopamine to effects on secretion of bile in the intestines.(reference enhancement jujunem) (Reference dopamine) Due to the vast array of functions that these proteins serve and their high abundance within the body, these proteins have become a major site of drug targets in medicine making a deeper, more in depth understanding of these proteins very important. (drug discovery) There are currently no NTRS1 structures of the inactive state, so there is no way to determine the conformational changes of the binding pocket caused by the binding of NT. (reference Agonist-bound) | ||
- | + | == Neurotensin == | |
== Structure == | == Structure == | ||
=== Overall Structure === | === Overall Structure === |
Revision as of 04:03, 29 March 2016
Neurotensin Receptor (Rattus norvegicus)
|
References
Millar, Robert P., and Claire L. Newton. "The year in G protein-coupled receptor research." Molecular endocrinology 24.1 (2010): 261-274.
Fredriksson, Robert, et al. "The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints." Molecular pharmacology 63.6 (2003): 1256-1272.
Gui, Xianyong, and Robert E. Carraway. "Enhancement of jejunal absorption of conjugated bile acid by neurotensin in rats." Gastroenterology 120.1 (2001): 151-160.
Binder, Elisabeth B., et al. "Neurotensin and dopamine interactions."Pharmacological reviews 53.4 (2001): 453-486.
Fang, Ye, Joydeep Lahiri, and Laurent Picard. "G protein-coupled receptor microarrays for drug discovery." Drug discovery today 8.16 (2003): 755-761.
White, Jim F. et al. “Structure of the Agonist-Bound Neurotensin Receptor.” Nature 490.7421 (2012): 508–513. PMC. Web. 29 Mar. 2016.
Krumm, Brian E., et al. "Structural prerequisites for G-protein activation by the neurotensin receptor." Nature communications 6 (2015).